Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

Dr David Johnson discusses recent findings indicating that vitamin D deficiency may contribute to the development of various ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial ...

The authors detail how a balanced microbiome (eubiosis) sustains immune tolerance and systemic health, while dysbiosis ...

Body cooling is death's reliable herald. Discover how this temperature decline occurs, what it reveals about our final hours, ...

In an 8 to 1 vote, the Oncologic Drug Advisory Committee determined that findings from the phase 3 STARGLO trial are not applicable to patients in the US with diffuse large B-cell lymphoma.

Researchers have traced where and when the HIV protective mutation arose but also how it gave northern European ancestors a competitive advantage against ancient diseasesA genetic mutation in a ...

Poolbeg Pharma plc (AIM: POLB) has today announced its Results for the year ended 31 December 2024. The Company has also announced a proposed conditional fundraising to raise gross proceeds of, in ...